Systemic lupus erythematosus (SLE) has a complex etiology and is affected by both genetic and environmental factors. Although more than 40 loci have shown robust association with SLE, the details of these loci, such as the independent contributors and the genes involved, are still unclear. In this study, we performed meta-analysis of two existing genome-wide association studies (GWASs) on Chinese Han populations from Hong Kong and Anhui, China, and followed the findings by further replication on three additional Chinese and Thailand cohorts with a total of 4254 cases and 6262 controls matched geographically and ethnically. We discovered multiple susceptibility variants for SLE in the 11q23.3 region, including variants in/near PHLDB1 (rs11603023, P_ combined 5 1.25E208, OR 5 1.20), DDX6 (rs638893, P_ combined 5 5.19E207, OR 5 1.22) and CXCR5 (rs10892301, P_ combined 5 2.51E208, OR 5 0.85). Genetic contributions from the newly identified variants were all independent of SNP rs4639966, whose association was reported from the previous GWAS. In addition, the three newly identified variants all showed independent association with the disease through modeling by *
INTRODUCTION
Systemic lupus erythematosus (SLE) is a heterogeneous disease characterized by various aberrations in the immune system, typically leading to the formation of autoantibodies against nucleic acid and associated proteins (1) . Both cellular and hormonal regulatory mechanisms fail to terminate the process, while inflammation and tissue injury lead to amplification and perpetuation of end-organ damage. Due to tissue damage caused by immune complex deposition, SLE usually presents with a diverse spectrum of clinical symptoms, including skin rash, anti-double stranded DNA (dsDNA) autoantibody production, renal involvement and other manifestations (2) .
SLE has a complex etiology, affected by both genetic and environmental factors. The disease concordance rate is between 20 and 59 for monozygotic twins, and the risk for siblings of affected individuals is 30 times higher than that for the general population, indicating important genetic contributions (3, 4) . The disease prevalence also varies with ethnicity, being higher in non-European populations (approximately 1:500 in populations with African ancestry versus. 1:2500 in Northern Europeans) (5) . In Hong Kong, the prevalence and annual incidence of SLE are estimated to be 0.1% and 6.7 cases/100 000 individuals, respectively (6) . In addition to genetic effects, environmental factors such as smoking and exposure to ultraviolet light have also been implicated in the disease (7) . The possibility that viruses may trigger SLE has also been speculated in the past, with observations of faster seroconversion to Epstein-Barr virus (EBV) infection (8) and higher viral load (9) in individuals affected with SLE than in normal subjects. In addition, the molecular similarity between EBV nuclear antigen and the common lupus autoantigen Ro also suggested potential roles of virus infection in SLE pathogenesis (10) .
Since the application of genome-wide association studies (GWASs) on complex traits, significant progress has been made in identifying novel susceptibility loci for SLE (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . However, the genetic basis of SLE still remained largely undetermined. So far more than 40 loci were demonstrated to have robust association with the disease, yet they only explain a small proportion of the disease heritability (28) . Even among those established loci, there still exists much ambiguity. One of the possible reasons is that for most GWASs, only the most significant SNP from a locus is followed up and eventually established, while in reality there could be multiple variants independently associated with the underlying disease in a given region. The independent variants are often overlooked and this may result in underestimation of explained disease heritability. A recent study carried out by Ke (29) demonstrated the presence of those multiple independent effects in loci of several other complex diseases, and found that the variance explained by the multiple effects in a locus was much higher than the variance explained by the single SNP reported. In addition, a recent study by our own group reported five loci to be associated with SLE susceptibility, and for two of them, multiple independent variants were confirmed (30) . Thus, further exploration of those independent effects will not only enrich the list of SLE susceptibility genes, but also has a potential to advance our understanding on the etiology of this complicated disease.
The 11q23.3 genomic region has attracted much attention for its role in several complex diseases. Multiple genes reside in this region spanning 5.3 Mb, including PHLDB1 (pleckstrin homologylike domain, family B, member 1), DDX6 (DEAD (AspGlu-Ala-Asp) box helicase 6), TREH (trehalase, brush-border membrane glycoprotein) and CXCR5 (chemokine (C-X-C motif) receptor 5). SNP rs498872, which was located in the upstream of PHLDB1, was found to be associated with glioma (31) . SNP rs6421571, a variant 10 kb upstream of CXCR5, showed close association with primary billiary cirrhosis (PBC) (32) , and another SNP located in the promoter region of CXCR5, rs630923, was reported as associated with multiple sclerosis (MS) (33) . SNP rs10892279, located in the promoter region of DDX6 gene, showed significant association with both celiac disease (CD) and rheumatoid arthritis (RA) (34) . Two studies on SLE also identified signals in this region. SNP rs503425, a variant located between DDX6 and CXCR5, showed suggestive association with SLE in US-Swedish cohorts (P_ combined ¼ 3.30E206) (19) . Another SNP, rs4639966, located downstream of DDX6, was established as associated with SLE in our previous work on a Chinese Han population from Anhui, China (P_ combined ¼ 1.30E216) (35) . However, due to the high gene density in this region, many details still remain elusive. Moreover, it is not clear whether these association signals point to a single biological pathway or a single gene, or they have different underlying biological implications. A more detailed elucidation of genetic variants in this region may help us better understand these issues.
In this study, we focused on exploring independent susceptibility variants for SLE in the 11q23.3 region and the relationship of these variants with those identified for SLE in different populations and from studies of other diseases. Through meta-analysis of two existing GWASs on Chinese Han populations from Hong Kong and Anhui, and further replication on three additional Chinese and Thailand cohorts with a total of 4254 cases and 6262 controls matched geographically and ethnically, we identified multiple independent variants associated with SLE in the 11q23.3 region, and showed that they had little linkage disequilibrium (LD) with variants found in previous studies, suggesting complex biological mechanisms for the involvement of this region in disease pathogenesis.
RESULTS

Meta-analysis of two existing GWASs on Chinese Han population from Hong Kong and Anhui
First, meta-analysis on genotyped SNPs was performed by METAL (36) , using effective sample size as weight from the two GWASs (940 and 1110 for the Hong Kong and Anhui studies, respectively) (35, 37, 38 Table S1 , SCAN annotation). RegulomeDB (40) annotations were also investigated to identify SNPs in or near regulatory elements, and several such imputed SNPs were found and they are in high LD with the genotyped SNPs (r 2 ≥ 0.8) (Supplementary Material, Table S3 ). Although there is no evidence that these regulatory SNPs may be contributing to disease pathogenesis (they did not show better P-values and there are quite a few of them that are in high LD with each other), this analysis may provide information for future studies for understanding this region biologically.
Replication experiment
Further replication for selected SNPs were performed by a TaqMan SNP genotyping method using assay-on-demand probes and primers (Applied Biosystems) on the remaining samples from the Hong Kong cohort that were not included in the GWAS stage, samples collected from Bangkok, Thailand and samples from Anhui, China, that are independent of the samples from the Anhui GWAS cohort. As shown in Table 2 , both rs11603023 and rs10892301 showed genome-wide significance in association with SLE by joint analysis of data from all these cohorts (P_ combined ¼ 1.25E208 and 2.51E2 08, respectively), while SNP rs638893 had suggestive association with a P_ combined value of 5.19E207. The same trends were observed in all the cohorts for the three SNPs (Table 2) , and testing of between-population heterogeneity of odds ratios (ORs) by the Breslow-Day method (41) did not show significant difference between cohorts (P_ het . 0.09, Table 2 ). 
Independence test and estimation of variance in liability explained (Vg)
A stepwise logistic regression analysis was performed to test independence of these SNPs. The method begins with an empty model, to which the variables are added one by one. This analysis showed that rs11603023 exhibited the strongest association with SLE. Subsequent additions of rs10892301 and rs638893 also significantly improved the model, providing further evidence to support the notion that multiple variants in the 11q23.3 region are independently associated with the disease (Table 3) . Further addition of rs4639966 did not show significant improvement in this model (P ¼ 0.306), which might be explained by its relatively small effect size in the current samples. The independent contributions of the identified SNPs were also supported by an increase in OR values in the analysis of each individual cohort (Supplementary Material, Table S4 ). Conditional logistic regression analysis was also performed to investigate the independent effects among these replicated SNPs. The result showed that the newly identified SNPs (rs11603023, rs10892301 and rs638893) were all independent of the reported SNP rs4639966, since all of them remained significant while the effect from rs4639966 was adjusted (shown in Table 4 , last column). In order to find residual association after each step of the analysis, we also showed the P-values of these SNPs after adjusting for the effect from (i) the most significant SNP (rs11603023); (ii) rs11603023 plus the variant with the highest residual association (rs10892301) and (iii) rs11603023, Figure 1 . Regional association plot for SNPs in the 11q23.3 region. SNPs are plotted by the chromosomal position (GRCh37/hg19; x axis) and association with SLE from the GWAS (2log 10 P-value; y-axis). The strongest signal from SNP rs10892301 is labeled in the plot, and other SNPs are colored to reflect their LD with the top SNP (based on the pairwise r 2 values from the meta-analysis data). Estimated recombination rates (from hg19/1000 Genomes Mar 2012 ASN) are plotted to reflect the local LD structure. Genes are indicated in the lower panel of the plot. The four selected SNPs for replication are labeled by arrows, including rs4639966 reported in the previous GWAS. The figure was generated using LocusZoom (39). Fig. S2A and B) .
With the presence of multiple independent effects in this region, the proportion of heritability explained by this region would probably increase. For the assessment of such increase, the contribution of individual variant to disease heritability was estimated with an algorithm developed by So et al. (28) under a disease-liability model. The results showed that the heritability explained by the three independent SNPs was much higher than that explained by the previously reported SNP rs4639966 ( Table 2 , shown as Vg).
In addition, haplotype analysis indicated that TCA haplotype formed by the three SNPs, rs11603023, rs4639966 and rs10892301, was the major risk haplotype, while the CTG haplotype was the major protective haplotype in all the three cohorts (Supplementary Material, Table S5 ). The same trend was observed when another SNP with suggestive significance, rs638893, was included in the haplotype analysis. However, probably due to the lower allele frequency of rs638893 (18, 11 and 16% in HK, AH and Thai controls, respectively), including this SNP did not increase significance in disease association (Supplementary Material, Table S5 ).
Sub-phenotype analysis
A case-only analysis was performed on the Hong Kong cohort to detect potential genetic association of the variants with specific subphenotypes. As presented in Table 5 , SNP rs11603023 showed significant association with anti-dsDNA antibody production (OR ¼ 1.32, P_ corrected ¼ 0.0153), and SNP rs10892301 showed marginal significance on early-onset cases versus those with onset age ≥18 years (OR ¼ 1.29, uncorrected P ¼ 0.04935), although the P-values did not withstand correction for multiple testing by 10 000 permutations. For the other 22 subphenotypes tested, no significant association was observed and further confirmation from additional cohorts would be needed.
SNPs in this region associated with other complex diseases
For the purpose of finding potentially shared susceptible variants/pathways between SLE and other immune-related diseases, we examined our meta-analysis data on SNPs in this region which showed association with other immune-related diseases. Results suggested that none of them showed strong evidence of association with SLE in these Asian populations (Table 6 and Supplementary Material, Table S6 ), and these SNPs are also in low LD with the four replicated SNPs in the current study and previous GWASs (Supplementary Material, Fig. S2C and D) pointing to potential differences in the biological mechanisms behind these association signals. Our comparison also suggests differences in genetic variants in SLE association between different populations. Of note, based on imputation data, rs503425, an SNP with suggestive significance for SLE association in the US -Swedish cohorts (19) (P_ combined ¼ 3.30E206) did not show evidence of association in the two Chinese cohorts (P_ meta ¼ 0.3059), and this SNP have high allele frequencies in both populations (36% in Asians and 20% in Europeans). Thus, study power is unlikely to be the explanation for this population difference in association signals.
DISCUSSION
In this study, through meta-analysis of two existing GWASs on Chinese Han populations, and further replication on three additional Chinese and Thailand cohorts, with a total number of 4254 cases and 6262 controls matched geographically and ethnically, we have identified multiple independent variants associated with SLE in the 11q23.3 region. Among those variants, an intronic SNP in PHLDB1, rs11603023, demonstrated the most significant association with SLE (P_ combined ¼ 1.25E208, OR_ combined ¼ 1.20). SNP rs10892301, which was located upstream of CXCR5, showed genome-wide significance as well The independent effects found for the three novel variants in this region were supported by strong evidence. Based on our results, all the three SNPs remained significant while the effect of rs4639966 was adjusted, and independent contributions also existed among the three novel variants (Tables 3 and 4) . These three SNPs, together with the previously established SNP rs4639966, increased the proportion of heritability explained by this region. Our current study also highlighted the complexity of this region. Although many GWAS hits were aggregated in this region, none of them (or proxies of them based on LD information from Asian populations or European populations, r 2 ≥ 0.8) showed strong evidence of association with SLE by the current investigation, and they also have little LD between each other. Interestingly, SNP rs638893, which revealed suggestive association with SLE susceptibility in the current study, was recently demonstrated as associated with vitiligo, an autoimmune disease presented with progressive loss of skin pigmentation, in a Chinese Han population (P_ combined ¼ 2.47E209, OR ¼ 1.22) (42). The same susceptible variant for both SLE and vitiligo in this locus may imply a potentially shared biological pathway for the two autoimmune diseases. Interestingly, rs503425, a SNP showed association with SLE in a study of European populations, did not show evidence in our meta-analysis (P_meta ¼ 0.3059), hinting potential differences between major ethnicities even the same region was found to be associated with the same disease, as demonstrated on several loci in our previous study (30) .
Obviously, the exploration of independently contributing variants from this region is mainly based on the meta-analysis data and on replication of a limited number of variants and is by no means complete. For example, two SNPs in high LD with each other in PHLDB1, SNP rs2077173 and SNP rs12798453, showed suggestive association signals with SLE (P_ meta ¼ 9.10E204 and 9.84E204, respectively). These two SNPs do not have high LD with the newly identified SNP rs11603023 or the other three SNPs shown in Table 2 (r 2 , 0.3) and whether this association is valid remains to be determined. Therefore, it is possible that even more variants may be independently associated with SLE in this region of high interest and identification of their roles requires further investigation in the future. It is also realized that the power of detecting independent signals is much smaller than focusing on a top signal from a single locus, thus much larger sample size is needed. In addition, there still exists certain possibility that currently identified susceptibility variants for SLE in the 11q23.3 region are just the tag-SNPs that have high LD with an unknown functional variant, although imputation results did not reveal consistent and clear signals that may better explain the association seen in this region (Supplementary Material, Tables S1 -S3). The imputed SNPs either showed differences in association between Hong Kong and Anhui cohorts, or they have high LD with the replicated SNPs and comparable P-values. Functional annotations from RegulomeDB also did not reveal any clear hint worth pursuing at this moment.
To identify how those loci might influence SLE susceptibility, we further investigated the potential biological function of the three putative susceptibility genes in this region (PHLDB1, DDX6 and CXCR5). PHLDB1 has been shown to be an insulinresponsive protein that enhances AKT activation (43) . AKT signaling pathway plays an important role in cellular proliferation and growth signaling. It was demonstrated that murine models with an activated PI3 K/AKT/mTOR signaling pathway in lymphocytes developed features of systemic autoimmunity, linking this pathway to autoimmune diseases (44) . Abnormal activation of the AKT signaling pathway was also found in peripheral blood T cells from individuals with SLE (45, 46) . In addition, based on the results from the ENCODE project (http://genome.ucsc.edu/ ENCODE/), the intronic susceptible variant, rs11603023, is suggested to locate in a binding site for transcription factor TAF1, which is known to be involved in the progression of G1 phase of the cell cycle. SNP rs11603023 is in high LD (r 2 ≥ 0.8) with several imputed SNPs that may locate in regulatory elements based on RegulomeDB annotations (Supplementary Material, Table S3 ), although further study is needed to elucidate functional implications, if any, of all these SNPs in disease pathogenesis.
DDX6 encodes a member of the DEAD box protein family (47) . The protein is an RNA helicase found in P-bodies and stress granules, which functions in translation suppression, mRNA degradation and microRNA-induced gene silencing (48) . Of note, transfected miR-146a was demonstrated to produce a comparable increase in the number of P-bodies, and this was accompanied by a reduction in major cytokines/chemokines induced by lipopolysaccharide (49) . Interestingly, a functional variant related to miR-146a expression was also identified to confer disease risk of SLE in our previous study (rs57095329, P_ meta ¼ 2.74E208, OR ¼ 1.29) (27) , and these findings together may indicate a vital role of DDX6 and microRNA in the etiology of SLE.
While the detailed functions of PHLDB1 and DDX6 are still unknown, another potential susceptibility gene suggested in this study, CXCR5 is well studied and its involvement in 822 HK SLE cases showed dsDNA-positive manifestation, while 345 HK SLE cases showed dsDNA-negative manifestation. 122 HK SLE cases developed the disease on or before 18 years. old, and 1009 HK SLE cases developed the disease after 18 years. P_ corrected is the value that is corrected for multiple comparisons by controlling the familywise type I error rate (FWER) using 10 000 permutations.
Human
autoimmunity is well supported by numerous functional studies. CXCR5 encodes a multi-pass membrane protein that belongs to the CXC chemokine receptor family. Being involved in B-cell migration, CXCR5 is enriched in mature B-cells and Burkitt's lymphoma (50, 51) . In addition, CXCR5 has also been demonstrated to be constitutively expressed by follicular helper T lymphocytes (T fh ), which are involved in autoantibody production and systemic autoimmunity (52, 53) .
In conclusion, focusing on the 11q23.3 region with proven association with SLE from previous work, we have identified three novel and independent susceptibility variants for SLE in this region via meta-analysis and further replication in independent cohorts. The presence of multiple independent-associated variants in this region significantly increased its total contribution to genetic variance explained. The putative susceptibility genes identified in this study suggest roles of AKT signaling pathway, RNA-induced silencing and chemokine/chemokine receptor axis in SLE pathogenesis. Our findings may enrich the list of SLE susceptibility genes as well as advance our knowledge on the etiology of this complicated disease. In addition, the discrepancy of risk variants in the 11q23.3 region in association with SLE and other diseases with immune-related components (shown in Table 6 and Supplementary Material, Table S6 ) indicates that certain regions in our genome may be involved in multiple diseases but through different and complicated biological mechanisms. Understanding the biology of these regions has a long way to go, but they may open a new door for us to better elucidate disease pathogenesis.
MATERIALS AND METHODS
Samples used in this study were collected from Hong Kong, Anhui province, China and Bangkok, Thailand, respectively. The Hong Kong cases were SLE patients visiting five hospitals in Hong Kong: Queen Mary Hospital, Tuen Mun Hospital, Queen Elizabeth Hospital, Pamela Youde Nethersole Eastern Hospital and Princess Margaret Hospital. They were all of selfreported Chinese ethnicity living in Hong Kong. Clinical and serological data and autoantibody profiles were both recorded at the time of diagnosis and subsequent doctor visits, which were also reviewed at the time of sample collection. The records include 22 kinds of information, including gender, age of onset, autoantibody profiles (anti-ANA, anti-dsDNA, IgG, IgM, anti-Sm, aPL, anti-La, anti-Ro, anti-nuclear factor and anti-RNP) and clinical manifestations including malar rash, discoid rash, photosensitivity, oral ulcer, arthritis, serositis, renal involvement, neurological involvement, haematological involvement and immunological involvement. Controls for the Hong Kong cohort were healthy blood donors from the Hong Kong Red Cross (for the Hong Kong Replication Panel) and individuals from other GWAS studies conducted in the University of Hong Kong, genotyped on the same platform at the same time (GWAS stage). SLE cases for Anhui Replication were all selfreported Chinese ethnicity living in Anhui province, central China, visiting Departments of Rheumatology at Anhui Provincial Hospital and the First Affiliated Hospital of Anhui Medical University in Hefei, Anhui Province. Controls were selected from a pool of healthy blood donors recruited from Hefei, Anhui province, with an effort to match for the age and sex of 
Genotyping
The two GWASs from Hong Kong and Anhui were conducted as previously reported (35, 37, 38) , both by Illumina 610-Quad Human Beadchip array. Further replication for selected SNPs was performed by a TaqMan SNP genotyping method using assay-on-demand probes and primers (Applied Biosystems, Foster City, CA, USA; Catalog nos. C__31695728_10 for rs11603023, C__27999313_10 for rs4639966, C__1052268_10 for rs638893, C__31035641_10 for rs10892301) on the remaining samples from Hong Kong that were not included in the GWAS stage, samples collected from Bangkok, Thailand, and samples from an independent Anhui cohort. Genotyping accuracy was confirmed by direct sequencing of polymerase chain reaction products for some randomly chosen samples, which showed 100% concordance. Genotyping concordance between Illumina Human 610-Quad Beadchip and Taqman SNP genotyping method was also checked on randomly selected samples and the two methods showed complete concordance.
Imputation
To obtain genotypes of additional 11q23.3 SNPs, SNP genotypes in Chromosome 11 of 286 Asians from the 1000 Genome Project (June 2011 data release) were used as the reference in imputation for Hong Kong and Anhui subjects. Imputation was performed using IMPUTE2.1.1 (54) , and imputed SNPs with an information score of .0.9 were included for further analyses.
Association analysis
The same quality control criteria were applied to process both genotyped and imputed SNPs. After a quality control process removing SNPs with low call rates (,90%), low minor allele frequencies (,1%) and violation of the Hardy-Weinberg equilibrium (P ≤ 10
24
), and removing samples with low call rates (,90%) and hidden relationship detected using PLINK (41), 325 324 variants in Chr11, 1047 cases and 1205 controls from the Anhui cohort, and 324 795 variants in Chr11, 612 cases and 2193 controls from the Hong Kong cohort were analyzed.
A weighted z-score method was used for meta-analysis. To combine results across different cohorts, alleles were oriented to the forward strand of NCBI reference sequence of the human genome to avoid ambiguity associated with C/G and A/T SNPs. Association P-values for each cohort were converted to z scores, taking into account the direction of association relative to an arbitrary reference allele. A weighted sum of z scores was calculated by weighing each z score by the square root of the quotient of effective sample size for each cohort and sum of the total cohort sample size. The meta-analysis z score was then converted to P-values from a chi-square distribution. The number of overlapped genotyped SNPs and imputed SNPs in 11q23.3 from Hong Kong and Anhui cohorts is 1072 and 14 980, respectively. The meta-analysis was carried out using METAL (36) .
Joint analysis of association, taking into account the effect of SNP differences between cohorts, was conducted using Cochran-Mantel-Haenszel, and homogeneity of the effect size between different cohorts and different stages of the study was tested by the Breslow -Day test (P_ het in Table 2 ), both installed in PLINK. Conditional and stepwise logistic regression methods were used to determine whether independent effects existed. Conditional logistic regression was done by SNPTESTv2.4.1, adjusted for the effect of other SNP(s) in the same locus, also treating potential differences among cohorts as a covariate.
Stepwise logistic regression was performed by SPSS 16.0. Briefly, variables were added to the logistic regression equation one at a time, using the statistical criterion of reducing the 22Log Likelihood error for the included variables. After each variable was entered, each of the included variables was tested to see if the model would be better off if the variable was excluded. The process of adding more variables stops when all of the available variables had been included or when it was not possible to make a statistically significant reduction in 22Log Likelihood using any of the variables not yet included. The order of entry the variables to the logistic regression equation can be used as a measure of relative importance.
Explained variance was estimated with the R algorithm reported by So et al. (28) by using the OR, allele frequency and disease prevalence. Briefly, a multifactorial liability threshold model was applied for assessing the contribution of individual variants to the total heritability. This model proposed a latent continuous liability, which was assumed to follow a normal distribution with mean 0 and variance 1. The model was theoretically justified by the central limit theorem, as the overall liability was assumed to be composed of many genetic variants and other risk factors with modest effects. The disease was assumed to be present in individuals whose liability exceeded a certain threshold (T), and was absent in other individuals. Variance in liability explained (Vg) by a variant can be directly interpreted as the locus-specific heritability. 
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